Trial
NCT02659800
Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
National Cancer Institute (NCI); NeoImmuneTech
Condition
Lymphopenia
Intervention
Laboratory Biomarker Analysis
Why stopped
Terminated \[NCI decided to terminate ABTC Consortium due to NCI moving in different direction for Brain Cancer\]
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-06